HomeCLSD • NASDAQ
add
Clearside Biomedical Inc
Previous close
$0.35
Day range
$0.32 - $0.35
Year range
$0.29 - $1.65
Market cap
25.06M USD
Avg Volume
603.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 492.00K | 446.67% |
Operating expense | 4.06M | -47.14% |
Net income | -4.50M | 40.81% |
Net profit margin | -913.62 | 89.17% |
Earnings per share | -0.06 | 40.00% |
EBITDA | -3.48M | 53.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.38M | -68.07% |
Total assets | 15.33M | -54.82% |
Total liabilities | 64.07M | 2.97% |
Total equity | -48.73M | — |
Shares outstanding | 78.51M | — |
Price to book | -0.56 | — |
Return on assets | -50.97% | — |
Return on capital | -113.99% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -4.50M | 40.81% |
Cash from operations | -4.73M | 16.74% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 477.00K | — |
Net change in cash | -4.25M | 75.16% |
Free cash flow | -5.22M | -0.52% |
About
Founded
2011
Headquarters
Website
Employees
32